Saturday 06/Sep/2025 – 09:47 PM
The Egyptian Pharmaceutical Authority has announced that it has granted companies that owns pharmaceutical preparations that contain Red Dye 3 E127 or any of its other names such as Acid Red 51, Erythrosine, Ci Food Red 3, Cino.45430, a three -year period of time starting from the date of the technical committee’s decision or when re -registering the product – whichever is further – to delete this article or replace it with alternatives Safe.
The Drug Authority gives companies a 3 -year deadline to delete a colored material from preparations
The Medicine Authority stated, in a post, that the decision came based on the recommendation of the Pharmaceutical Woding Committee, which recommended that the matter be referred to the technical committee to monitor medicines to consider the possibility of stopping the use of Red Dye 3 as a colorful substance in medications given by mouth, provided that the endowment is applied gradually over several years.
The authority added that the recommendation was based on the results of studies conducted by the American Food and Drug Administration on experimental animals, and showed the possibility of a carcinogenic effect of the material when using it in high doses, which prompted the need to start searching for natural alternatives to this substance.
The Egyptian Pharmaceutical Authority confirmed that the General Administration of Pharmacological Vigilance will follow any new signals issued by the global health authorities such as EMA, swissmedic, health Canada, PMDA, MHRA regarding the integrity of this article, while re -presenting the topic to the technical committee in the event of scientific developments.
